Press "esc" to clear
Go to Advanced Search
Showing results 5160 of 6238
CoverArt_ChemoresistantCell.jpg

Article ID: 704966

UC San Diego Researchers Develop Sensors to Detect and Measure Cancer’s Ability to Spread

University of California San Diego Health

University of California San Diego School of Medicine researchers engineered sensors to detect and measure the metastatic potential of single cancer cells. Metastasis is attributed as the leading cause of death in people with cancer.

Released:
5-Dec-2018 11:05 AM EST

Article ID: 704949

Using graphene to detect ALS, other neurodegenerative diseases

University of Illinois at Chicago

The wonders of graphene are numerous — it can enable flexible electronic components, enhance solar cell capacity, filter the finest subatomic particles and revolutionize batteries. Now, the “supermaterial” may one day be used to test for amyotrophic lateral sclerosis, or ALS — a progressive, neurodegenerative disease which is diagnosed mostly by ruling out other disorders, according to new research from the University of Illinois at Chicago published in ACS Applied Materials & Interfaces.

Released:
5-Dec-2018 10:05 AM EST

Article ID: 704947

Científicos de Mayo Clinic identifican nuevas estrategias para mejorar terapia de células T con receptor de antígeno quimérico

Mayo Clinic

Los científicos de Mayo Clinic desarrollaron dos estrategias nuevas que podrían mejorar el rendimiento de la terapia de células T con receptor de antígeno quimérico en el tratamiento del cáncer.

Released:
5-Dec-2018 10:05 AM EST
  • Embargo expired:
    5-Dec-2018 5:05 AM EST

Article ID: 704825

Scientists Identify ‘Youth Factor’ in Blood Cells That Speeds Fracture Repair

Duke Health

Duke Health researchers have previously shown that introducing bone marrow stem cells to a bone injury can expedite healing, but the exact process was unclear. Now, the same Duke-led team believes it has pinpointed the “youth factor” inside bone marrow stem cells -- it’s the macrophage, a type of white blood cell, and the proteins it secretes that can have a rejuvenating effect on tissue. Nature Communications will publish the findings online on Dec. 5.

Released:
3-Dec-2018 4:35 PM EST
  • Embargo expired:
    4-Dec-2018 4:00 PM EST

Article ID: 704677

Expanded Cord Blood Shows Potential for Use in Adult Bone Marrow Transplants

Duke Health

Umbilical cord blood stem cells that are cultured and expanded outside the body before being used for bone marrow transplant in adult blood cancer patients appear safe and restore blood count recovery faster than standard cord blood. The findings, led by a Duke Cancer Institute researcher, advance efforts to improve cord blood use among adults who have been diagnosed with blood cancers.

Released:
30-Nov-2018 10:05 AM EST
187613_web.jpg

Article ID: 704895

How microbial interactions shape our lives

Carnegie Institution for Science

Baltimore, MD--The interactions that take place between the species of microbes living in the gastrointestinal system often have large and unpredicted effects on health, according to new work from a team led by Carnegie's Will Ludington. Their findings are published this week in the Proceedings of the National Academy of Sciences.

Released:
4-Dec-2018 1:40 PM EST

Article ID: 704896

INSTITUTE OF HUMAN VIROLOGY RESEARCHERS DISCOVER THAT A BACTERIAL PROTEIN PROMOTES CANCER

University of Maryland Medical Center/School of Medicine

The Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) announced today the discovery that DnaK, a protein of the bacterium mycoplasma, interferes with the mycoplasma-infected cell’s ability to respond to and repair DNA damage, a known origin of cancer.

Released:
4-Dec-2018 1:05 PM EST

Article ID: 704871

Immunotherapy Pioneers Unveil Updated Efficacy Data of Single Infusion of Tisagenlecleucel CAR T-cell Therapy

Children's Hospital of Philadelphia

Physician-scientists from Children’s Hospital of Philadelphia presented updated efficacy and safety data on Kymriah (tisagenlecleucel) --the first-ever FDA-approved personalized CAR T-cell gene immunotherapy for aggressive blood cancers, at the American Society of Hematology annual meeting, as well as first-of-its-kind research on overcoming CAR T-cell resistance.

Released:
4-Dec-2018 1:00 PM EST

Article ID: 704875

Natural selection in the womb can explain health problems in adulthood

Columbia University, Mailman School of Public Health

Conditions encountered in the womb - when the embryo consists of only about 100 cells - can have life-long impact on health. Scientists previously assumed that this is because embryos respond to adverse conditions by programming their gene expression. Now an international team of researchers at the Leiden University Medical Center, Wageningen University and Research, Lund University, Columbia University Mailman School of Public Health in New York propose a radically different alternative. Rather than being programmed by the environment, random differences in gene expression may provide some embryos with a survival advantage, in particular when conditions are harsh. By studying DNA methylation, an important mechanism to control gene activity, the researchers found that a specific part of the DNA methylation pattern was missing among famine-exposed individuals. The findings are published in the journal Cell Reports.

Released:
4-Dec-2018 12:55 PM EST
460A4311.jpg

Article ID: 704885

Innovative Stem Cell Therapeutic Strategy May be Transformative for Heart Failure Treatment

MedStar Heart & Vascular Institute and the Cleveland Clinic Heart and Vascular Institute

The FDA has approved an investigational new drug clinical trial that will start shortly at MedStar Heart & Vascular Institute, to determine whether stem cell therapy improves myocardial function in patients with severe heart failure—severe enough to require the implantation of a left ventricular assist device, or LVAD.

Released:
4-Dec-2018 12:05 PM EST

Showing results 5160 of 6238

Chat now!